Related Experiment Video

Updated: Jun 30, 2026

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
09:00

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease

Published on: October 31, 2012

[Reevaluation of mechanisms of GVHD and GVL]

Takanori Teshima

    [Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
    |September 20, 2008
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice
    09:50

    Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice

    Published on: February 11, 2019

    Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR
    06:06

    Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR

    Published on: May 23, 2019

    Related Experiment Videos

    Last Updated: Jun 30, 2026

    High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
    09:00

    High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease

    Published on: October 31, 2012

    Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice
    09:50

    Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice

    Published on: February 11, 2019

    Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR
    06:06

    Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR

    Published on: May 23, 2019

    Related Concept Videos

    Graves Disease II: Pathophysiology01:24

    Graves Disease II: Pathophysiology

    Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...

    Articles linked to this work by shared authors, journal, and citation graph.

    Simple LC-MS/MS Method for Ruxolitinib in Human Plasma and Its Clinical Application in Pediatric and Adult Patients.

    Biological & pharmaceutical bulletin·2026

    Donor and stem cell source selection in hematopoietic cell transplantation in the Asia-Pacific region: results from the APBMT Activity Survey 2022-2023.

    Blood cell therapy·2026

    Tandem Double Inversion Resolves the Structural Paradox Underlying Recurrent KAT6A::NCOA2 Fusion in Acute Myeloid Leukemia.

    Genes, chromosomes & cancer·2026

    Retrospective comparison of mesenchymal stromal cells and antithymocyte globulin as second-line therapy for acute graft-versus-host disease.

    Cytotherapy·2026

    Genome-wide CRISPR screens identify an RXR-MYLIP-LDLR axis regulating BH3 mimetic sensitivity in peripheral T-cell lymphomas.

    Oncogene·2026

    Early administration of calcineurin inhibitors limits tolerogenic effect of PTCy in allogeneic hematopoietic transplant.

    Blood·2026

    [Treatment landscape of mature NK/T-cell lymphomas: treatment outcomes in Japan and future prospects].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026

    [Prophylactic or pre-emptive therapy with azacitidine or FLT3 inhibitor after allogeneic hematopoietic stem cell transplantation for AML and MDS].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026

    [Prophylactic use of tyrosine kinase inhibitors after allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026

    [Development of universal off-the-shelf T cell therapies derived from ES/iPS cells for leukemia and COVID-19].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026

    [Predictors of treatment-free remission (TFR) and second TFR attempts in chronic myeloid leukemia].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026

    [Complement-coagulation crosstalk in immunothrombosis].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026

    A new era of research in the U.S. Department of War Serum Repository: a review of published studies, 2013-2024.

    MSMR·2026

    Case Report: Effective use of rituximab in children with steroid-resistant/dependent idiopathic pulmonary hemosiderosis: description of two cases and literature review.

    Frontiers in pediatrics·2026

    Diagnostic accuracy of Mycobacterium tuberculosis antigen-induced interferon-γ-inducible protein 10 for latent tuberculosis infection among high-risk groups: a systematic review and meta-analysis.

    Frontiers in immunology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us